RAREsummit19Talk synopsis & speaker profile
General Manager – UK & ROI, Sobi
Moderated Discussion: Disruptive technologies – Patients at the heart of AI
Bio: Neil Dugdale joined Sobi (Swedish Orphan Biovitrum at the beginning of 2015 and is the Vice-President for the UK-RoI;Nordics-Baltics and General Manager, UK and RoI. Previously he was Oncology Director, Merck Serono, and prior to that he was founder and owner of DGYC ltd, a company specialising in marketing consultancy and interim management in Pharmaceuticals and Medical Devices. He started working in the Pharmaceutical industry in 1994 as a Pharmaceutical Sales representative for Merck Pharmaceuticals (Merck KGaA). Neil is also a founding director of the not-for-profit organisation, Rare Disease Nurse Network, formed to connect nurses and other healthcare professionals and to build to be able to provide additional nurse support around the world for those affected by rare disease.
‘’I passionately believe that everyone in the healthcare sector can make an incredible positive difference to patient’s lives by helping healthcare professionals in many different ways so that they are able treat their patients in the best way possible. I believe it is our duty to help patient organisations so that they can continue their amazing work that gives so much help and support to patient’s and their families and friends.’’